– Global plasma fractionation market to expand 2x across the 2021-2031 assessment period – By application, neurology segment is expected to observe a CAGR of 7.2% through 2031 – Immunology segment is expected to multiply 1.5x in the forecast period by surpassing US$ 10 bn by 2031 – Hospitals to account for bulk of plasma fractionation therapies, accounting for 35% of total demand – By product, intravenous immunoglobulins to account for more than 2/5th of overall revenue